MoonLake Immunotherapeutics Announces Pricing of Upsized $200 Million Public Offering
MoonLake Immunotherapeutics priced an upsized $200 million public offering of 9 million Class A ordinary shares at $20.00 per share. The offering also includes 1 million pre-funded warrants priced at $19.9999 and a 30-day over-allotment option for 1.5 million additional shares.
Key figures
- Deal Value Usd
- 200000000
- Offering Price
- 20
- Shares Offered
- 9000000
- Prefunded warrants
- 1000000
- Over allotment shares
- 1500000
- Prefunded warrant price
- 19.9999
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.